Sonora Investment Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Sonora Investment Management’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3K	Hold	39	–	–	﹤0.01%	967
2021 Q2	$3K	Hold	39	–	–	﹤0.01%	873
2021 Q1	$3K	Hold	39	–	–	﹤0.01%	1641
2020 Q4	$2K	Hold	39	–	–	﹤0.01%	1605
2020 Q3	$2K	Hold	39	–	–	﹤0.01%	1662
2020 Q2	$5K	Hold	39	–	–	﹤0.01%	1381
2020 Q1	$2K	Hold	39	–	–	﹤0.01%	1513
2019 Q4	$5K	Hold	39	–	–	﹤0.01%	1424
2019 Q3	$5K	Hold	39	–	–	﹤0.01%	1413
2019 Q2	$12K	Hold	39	–	–	﹤0.01%	1068
2019 Q1	$18K	Hold	39	–	–	﹤0.01%	837
2018 Q4	$18K	Buy	39 +6	+18%	+$3.72K	﹤0.01%	682
2018 Q3	$30K	Buy	33 +14	+74%	+$9.24K	﹤0.01%	512
2018 Q2	$11K	Hold	19	–	–	﹤0.01%	762
2018 Q1	$12.7K	Hold	19	–	–	﹤0.01%	703
2017 Q4	$7.11K	Sell	19 -12	-39%	-$4.58K	﹤0.01%	897
2017 Q3	$9.35K	Buy	31 +12	+63%	+$4.56K	﹤0.01%	744
2017 Q2	$9.31K	Hold	19	–	–	﹤0.01%	743
2017 Q1	$24.2K	Hold	19	–	–	﹤0.01%	475
2016 Q4	$7.84K	Hold	19	–	–	﹤0.01%	646
2016 Q3	$7.95K	Hold	19	–	–	﹤0.01%	630
2016 Q2	$9.52K	Hold	19	–	–	﹤0.01%	604
2016 Q1	$10.2K	Buy	19 +11	+138%	+$6.15K	﹤0.01%	641
2015 Q4	$7K	Buy	8 +5	+167%	+$4.92K	﹤0.01%	598
2015 Q3	$3K	Buy	+3	New	+$4.63K	﹤0.01%	934

Other funds holding HTGM

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sonora Investment Management's HTGM Position: Q3 2021 in Review

Sonora Investment Management held its HTG Molecular Diagnostics, Inc. Common Stock (HTGM) position steady in Q3 2021 at 39 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Sonora Investment Management first reported a position in HTGM in Q3 2015 and has held it in 25 quarters since. The position peaked at $30K in Q3 2018. 23 funds tracked by Wall St. Rank hold HTGM as of Q3 2021.

Sonora Investment Management held 39 shares of HTG Molecular Diagnostics, Inc. Common Stock worth $3K as of Q3 2021.
Sonora Investment Management left its HTG Molecular Diagnostics, Inc. Common Stock share count unchanged in Q3 2021.
HTG Molecular Diagnostics, Inc. Common Stock made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #967 holding.
Sonora Investment Management first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q3 2015 and has held it in 25 quarters since.
Sonora Investment Management's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $30K in Q3 2018.
23 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.